BAG3 and neoplasm: As shown inFig. 4a (and Supplementary Fig. 6A), mice transplanted with the PDX, treated withthe anti-BAG3 mAb administered every 48 h, showed a significant delayof the growth of xenografted tumours compared with the control group.